Activist 13D/13G Filings - Kinnate Biopharma Inc. (KNTE)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, Next
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2024-04-05
4:15 pm
Sale
13DKinnate Biopharma Inc.
KNTE
Foresite Capital Fund V L.P.0
0.000%
-13,779,062decrease
(Position Closed)
View
2024-02-22
4:39 pm
Unchanged
13DKinnate Biopharma Inc.
KNTE
Foresite Capital Fund V L.P.13,779,062
29.200%
0
(Unchanged)
View
2024-02-21
4:11 pm
Unchanged
13DKinnate Biopharma Inc.
KNTE
ORBIMED ADVISORS LLC7,559,729
16.100%
0
(Unchanged)
View
2024-02-14
4:16 pm
Sale
13GKinnate Biopharma Inc.
KNTE
Nextech V Oncology S.C.S. SICAV-SIF0
0.000%
-2,329,480decrease
(Position Closed)
View
2024-02-14
4:00 pm
Sale
13GKinnate Biopharma Inc.
KNTE
TANG CAPITAL PARTNERS LP2,601,647
5.500%
-364,068decrease
(-12.28%)
View
2024-02-14
09:21 am
Sale
13GKinnate Biopharma Inc.
KNTE
Lynx1 Capital Management LP1,997,006
4.200%
-216,172decrease
(-9.77%)
View
2023-11-27
4:47 pm
Purchase
13GKinnate Biopharma Inc.
KNTE
TANG CAPITAL PARTNERS LP2,965,715
6.300%
2,965,715increase
(New Position)
View
2023-11-17
08:27 am
Unchanged
13DKinnate Biopharma Inc.
KNTE
ORBIMED ADVISORS LLC7,559,729
16.000%
0
(Unchanged)
View
2023-11-17
08:00 am
Unchanged
13DKinnate Biopharma Inc.
KNTE
Foresite Capital Fund V L.P.13,779,062
29.200%
0
(Unchanged)
View
2023-11-14
4:57 pm
Unchanged
13DKinnate Biopharma Inc.
KNTE
ORBIMED ADVISORS LLC7,559,729
16.000%
0
(Unchanged)
View
2023-11-14
4:30 pm
Purchase
13DKinnate Biopharma Inc.
KNTE
Foresite Capital Fund V L.P.13,779,062
29.200%
13,779,062increase
(New Position)
View
2023-08-14
5:00 pm
Sale
13GKinnate Biopharma Inc.
KNTE
RA CAPITAL MANAGEMENT L.P.0
0.000%
-4,264,144decrease
(Position Closed)
View
2023-05-10
5:20 pm
Purchase
13DKinnate Biopharma Inc.
KNTE
Foresite Capital Fund IV L.P.13,718,311
29.500%
1,780,000increase
(+14.91%)
View
2023-05-08
5:01 pm
Purchase
13DKinnate Biopharma Inc.
KNTE
ORBIMED ADVISORS LLC7,559,729
16.200%
1,460,932increase
(+23.95%)
View
2023-05-02
7:28 pm
Purchase
13DKinnate Biopharma Inc.
KNTE
ORBIMED ADVISORS LLC6,098,797
13.100%
1,405,168increase
(+29.94%)
View
2023-04-06
09:29 am
Sale
13GKinnate Biopharma Inc.
KNTE
BlackRock Inc.
BLK
2,277,109
4.900%
-58,709decrease
(-2.51%)
View
2023-02-23
3:23 pm
Purchase
13DKinnate Biopharma Inc.
KNTE
ORBIMED ADVISORS LLC4,693,629
10.600%
1,295,700increase
(+38.13%)
View
2023-02-22
3:01 pm
Purchase
13DKinnate Biopharma Inc.
KNTE
Foresite Capital Fund IV L.P.11,938,311
25.600%
1,100,000increase
(+10.15%)
View
2023-02-14
4:45 pm
Purchase
13GKinnate Biopharma Inc.
KNTE
RA CAPITAL MANAGEMENT L.P.4,264,144
9.700%
671,092increase
(+18.68%)
View
2023-02-14
4:32 pm
Sale
13GKinnate Biopharma Inc.
KNTE
Nextech V Oncology S.C.S. SICAV-SIF2,329,480
5.300%
-678,763decrease
(-22.56%)
View
Goto 0, 1, Next